Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 784
Ph III recruiting: 82
Growth YoY: +24.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 51–100 of 297 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04633252	A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer	recruiting	Phase 1 / Phase 2	86	National Cancer Institute (NCI)NIH	1	Sep 3, 2026	clinicaltrials
NCT06515613	A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors	recruiting	Phase 1	156	Context Therapeutics Inc.INDUSTRY	2	Sep 3, 2026